GeoVax Labs, Inc.

NasdaqCM:GOVX Stock Report

Market Cap: US$23.3m

GeoVax Labs Future Growth

Future criteria checks 5/6

GeoVax Labs is forecast to grow earnings and revenue by 56.8% and 56.5% per annum respectively while EPS is expected to grow by 61.9% per annum.

Key information

56.8%

Earnings growth rate

61.9%

EPS growth rate

Biotechs earnings growth26.8%
Revenue growth rate56.5%
Future return on equityn/a
Analyst coverage

Low

Last updated18 Dec 2024

Recent future growth updates

Recent updates

We Think GeoVax Labs (NASDAQ:GOVX) Needs To Drive Business Growth Carefully

Sep 08
We Think GeoVax Labs (NASDAQ:GOVX) Needs To Drive Business Growth Carefully

GeoVax: Possible Vaccine Advancements In 2 Big Indications

Aug 08

GeoVax adds 16% as journal publishes animal study on ebolavirus vaccine

Jul 28

Companies Like GeoVax Labs (NASDAQ:GOVX) Could Be Quite Risky

May 24
Companies Like GeoVax Labs (NASDAQ:GOVX) Could Be Quite Risky

GeoVax: A Legitimate COVID-19 Phase 2 Vaccine Candidate Trading At Only A $25 Million Valuation

Dec 27

We Think GeoVax Labs (NASDAQ:GOVX) Can Afford To Drive Business Growth

Nov 27
We Think GeoVax Labs (NASDAQ:GOVX) Can Afford To Drive Business Growth

GeoVax: Expands Immuno-Oncology Pipeline With Clinical-Stage Program

Oct 03

We Think GeoVax Labs (NASDAQ:GOVX) Can Afford To Drive Business Growth

Aug 14
We Think GeoVax Labs (NASDAQ:GOVX) Can Afford To Drive Business Growth

Did Business Growth Power GeoVax Labs' (NASDAQ:GOVX) Share Price Gain of 111%?

Feb 18
Did Business Growth Power GeoVax Labs' (NASDAQ:GOVX) Share Price Gain of 111%?

GeoVax soars on NIAID grant for COVID-19 vaccine candidate

Jan 11

Earnings and Revenue Growth Forecasts

NasdaqCM:GOVX - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20273052023993992
12/31/20266-21-16-173
12/31/202514-15-17-175
12/31/20245-23-21-194
9/30/20243-24-27-27N/A
6/30/20240-27-23-23N/A
3/31/2024N/A-28-27-27N/A
12/31/2023N/A-26-25-25N/A
9/30/2023N/A-24-22-22N/A
6/30/2023N/A-19-21-21N/A
3/31/2023N/A-16-19-18N/A
12/31/20220-14-19-19N/A
9/30/20220-22-19-19N/A
6/30/20220-20-17-16N/A
3/31/20220-19-14-14N/A
12/31/20210-19-11-11N/A
9/30/20210-6-6-6N/A
6/30/20211-5-5-5N/A
3/31/20211-4-4-4N/A
12/31/20202-3-3-3N/A
9/30/20202-2-1-1N/A
6/30/20202-2-2-2N/A
3/31/20202-2-1-1N/A
12/31/20191-2-1-1N/A
9/30/20191-2-2-2N/A
6/30/20191-3-2-2N/A
3/31/20191-3-1-1N/A
12/31/20181-3-2-2N/A
9/30/20181-2-1-1N/A
6/30/20181-2N/A-2N/A
3/31/20181-2N/A-2N/A
12/31/20171-2N/A-2N/A
9/30/20171-3N/A-2N/A
6/30/20171-2N/A-2N/A
3/31/20171-3N/A-2N/A
12/31/20161-3N/A-2N/A
9/30/20161-3N/A-2N/A
6/30/20160-3N/A-3N/A
3/31/20160-3N/A-3N/A
12/31/20150-3N/A-3N/A
9/30/20150-3N/A-3N/A
6/30/20151-3N/A-2N/A
3/31/20151-3N/A-2N/A
12/31/20141-3N/A-2N/A
9/30/20141-3N/A-2N/A
6/30/20142-2N/A-2N/A
3/31/20142-2N/A-2N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: GOVX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).

Earnings vs Market: GOVX is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: GOVX is expected to become profitable in the next 3 years.

Revenue vs Market: GOVX's revenue (56.5% per year) is forecast to grow faster than the US market (9% per year).

High Growth Revenue: GOVX's revenue (56.5% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if GOVX's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 11:34
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

GeoVax Labs, Inc. is covered by 6 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James MolloyAlliance Global Partners
null nullCG Capital
Jason KolbertD. Boral Capital LLC.